LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Home・Akcijų sąrašas・CareDx Inc

CareDx Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

18.67 1.25

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

17.56

Max

18.88

Pagrindiniai rodikliai
By Trading Economics
Pajamos	10M 1.7M
Pardavimai	13M 100M
P/E Sektoriaus vid.	14.68 108.767
Pelno marža	1.674
Darbuotojai	644
EBITDA	11M 7.2M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+35.43% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-04-29

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	214M 1B
Ankstesnė atidarymo kaina	17.42
Ankstesnė uždarymo kaina	18.67

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

14.77 / 18.49 Palaikymas ir pasipriešinimas

CareDx Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-26 22:04; UTC

Uždarbis

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

2026-02-26 23:55; UTC

Rinkos pokalbiai

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

2026-02-26 23:40; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

2026-02-26 23:37; UTC

Rinkos pokalbiai

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

2026-02-26 23:32; UTC

Uždarbis

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

2026-02-26 23:19; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

2026-02-26 23:18; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

2026-02-26 23:12; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Global Equities Roundup: Market Talk

2026-02-26 23:12; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Gives Up in Bidding War Over Warner -- Market Talk

2026-02-26 23:01; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

2026-02-26 23:00; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

2026-02-26 23:00; UTC

Įsigijimai, susijungimai, perėmimai

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

2026-02-26 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

2026-02-26 22:43; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-26 22:43; UTC

Rinkos pokalbiai

RBA Hike In March Is Being Underpriced -- Market Talk

2026-02-26 22:33; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

2026-02-26 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

2026-02-26 22:13; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Bidding War Over Warner Bros. Set to Continue -- Market Talk

2026-02-26 21:59; UTC

Uždarbis

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

2026-02-26 21:58; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

2026-02-26 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-26 21:49; UTC

Uždarbis

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

2026-02-26 21:45; UTC

Uždarbis

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

2026-02-26 21:44; UTC

Uždarbis

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

2026-02-26 21:44; UTC

Uždarbis

Coles Expects Market to Remain Highly Competitive

2026-02-26 21:44; UTC

Uždarbis

Coles Says Supermarket Customers Remain Value Oriented

2026-02-26 21:43; UTC

Uždarbis

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

2026-02-26 21:43; UTC

Uždarbis

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

2026-02-26 21:42; UTC

Įsigijimai, susijungimai, perėmimai

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

2026-02-26 21:41; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

CareDx Inc Prognozė

Kainos tikslas

By TipRanks

35.43% į viršų

12 mėnesių prognozė

Vidutinis 25 USD 35.43%

Aukščiausias 28 USD

Žemiausias 21 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines CareDx Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

5 ratings

Pirkti

Laikyti

Parduoti

Remiantis 5 analitikų, pateikusių CareDx Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

14.77 / 18.49Palaikymas ir pasipriešinimas

The bullish and bearish events are balanced.

All events are bearish.

Bearish events outweigh bullish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.